AcquisitionOther
Processa Pharmaceuticals, Inc. acquired Vidya Therapeutics, Inc
Public M&A record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Processa Pharmaceuticals, Inc. -> Vidya Therapeutics, Inc · $200 million
"This transaction with Vidya represents a compelling opportunity to create meaningful value for our shareholders through the acquisition of a differentiated, clinical-stage BTK inhibitor program with the potential to address significant unmet needs across mult
Open source record (SEC) ↗